HOME >> BIOLOGY >> NEWS
After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis

A pair of large-scale genetic studies supported by the National Institutes of Health has revealed two genes that influence the risk of getting multiple sclerosis (MS) data sought since the discovery of the only other known MS susceptibility gene decades ago. The findings could shed new light on what causes MS a puzzling mix of genes, environment and immunity and on potential treatments for at least 350,000 Americans who have the disease.

"These studies describe the first genes conclusively linked to MS in more than 20 years," said Ursula Utz, Ph.D., a program director at the National Institute of Neurological Disorders and Stroke (NINDS), a part of NIH. This breakthrough was made possible through persistence, an elegant search strategy, and genomic data and techniques that were not available until recently.

Both studies involved scanning DNA samples from more than 20,000 MS patients and unaffected individuals in the U.S. and Europe, and looking for single nucleotide polymorphisms (SNPs), which are single-letter variations in a gene's DNA code. Published simultaneously today in the New England Journal of Medicine and Nature Genetics, the studies demonstrate an association between MS and SNPs in two genes that encode interleukin receptors, proteins that serve as antennae on the surface of immune cells.

Both studies were supported by NINDS and the National Multiple Sclerosis Society. The Nature Genetics study received additional support from the National Institute of General Medical Sciences (NIGMS). The NEJM study was also supported in part by the Penates Foundation.

They were conducted by overlapping teams of scientists that used different gene-hunting strategies. One team, which scanned the entire human genome for MS risk factors, was co-led by David Hafler, M.D., Professor of Neurology at Harvard Medical School and Brigham and Women's Hospital in Boston, Stephen Hauser, M.D., Professor and Chair of Neurolog
'"/>

Contact: Daniel Stimson
stimsond@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
29-Jul-2007


Page: 1 2 3 4

Related biology news :

1. After scrutiny, preemie lung treatments turn out to be safe, effective
2. After 2 years, study shows Revlimid patients live longer and remain transfusion free
3. After North Korea test, what can be done to reduce the growing nuclear threat?
4. After insects attack, plants bunker sugars for later regrowth
5. After the Hurricanes
6. After the yeast is gone bacteria continue to develop flavor of sparkling wine
7. After a time-shift, mixed signals from the circadian clock
8. After flu exposure, mild exercise protects mature mice from dying
9. Regulating Californian stem cell research, and more
10. March of Dimes awards $250K prize to stem cell research, reproductive biology pioneers
11. Experimental Biology 2007: Todays Research, Tomorrows Health, April 28-May 2

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/26/2019)... ... 25, 2019 , ... The team at Cieplak Dental Excellence ... myofunctional disorders (OMDs) are abnormal movement patterns of the face and mouth that ... from difficulty swallowing and limited tongue movement to an overbite. Participation in this ...
(Date:10/22/2019)... ... 2019 , ... Greenberg Traurig, LLP’s global Life Sciences & ... the Life Sciences Sector,” with German biotech strategy consulting firm, Catenion. The seminar will ... Tokyo office . , Speakers from Greenberg Traurig and Catenion will discuss best ...
(Date:10/17/2019)... HOUSTON, Texas (PRWEB) , ... October 15, 2019 ... ... engineering firm, is pleased to announce it made its first appearance on the ... two-year revenue growth of 56 percent. , With corporate headquarters in Houston, ...
Breaking Biology News(10 mins):
(Date:10/30/2019)... ... October 30, 2019 , ... Western ... many roles innovation and technology play in educating the next generation of health ... learning opportunities and presentations by WesternU administrators and representatives of companies working with ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality Solutions, a ... cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, November 11-12, ... The Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge technology providers, ...
(Date:10/26/2019)... ... 2019 , ... Sparks Marketing Group, Inc. (Sparks) ... boutique healthcare-specific marketing firm, to strengthen the agency’s growing focus on the healthcare ... clients in pharma, bio-therapeutics, medical device and healthcare technologies currently account for a ...
(Date:10/22/2019)... (PRWEB) , ... October 22, 2019 , ... Catalent, a ... Supply Services and Drug Product Technologies Integration, will participate in a panel session titled ... (HPCLC), to be held at the Gwen Hotel, Chicago, on Oct. 28-30, 2019. , ...
Breaking Biology Technology:
Cached News: